Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Edelman

Showing results (21-30 of 348) with videos related to

Pageof 35
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2020
Prophylactic Cranial Irradiation for Small-Cell Lung Cancer: Time for a ReassessmentMartin J Edelman
Clinical Lung Cancer|February 12, 2004
Gemcitabine and carboplatin regimens in advanced non-small-cell lung cancer: focus on randomized phase III trialsMartin J Edelman
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Second-line chemotherapy and beyond for non-small-cell lung cancerMartin J Edelman
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 25, 2010
EML4/ALK and ras inhibitorsMartin J Edelman
Cancer Journal (Sudbury, Mass.)|November 9, 2004
Evidence-based approaches to overcoming barriers to clinical trial accrualMartin J Edelman
Seminars in Oncology|February 7, 2006
An update on the role of epidermal growth factor receptor inhibitors in non-small cell lung cancerMartin J Edelman
Clinical Lung Cancer|October 28, 2005
The potential role of bortezomib in combination with chemotherapy and radiation in non-small-cell lung cancerMartin J Edelman
Lung Cancer (Amsterdam, Netherlands)|November 15, 2002
Past, present, and future of gemcitabine and carboplatin regimens in advanced non-small cell lung cancerMartin J Edelman
Expert Review of Anticancer Therapy|May 2, 2003
Taking stock of targeted therapy in cancer: rational expectations or irrational exuberance?Martin J Edelman
Expert Review of Anticancer Therapy|July 13, 2002
Neoadjuvant chemotherapy in early-stage non-small cell lung cancerM J Edelman
Pageof 35

Showing results (21-30 of 348) with videos related to

Sort By:
Pageof 35
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2020
Prophylactic Cranial Irradiation for Small-Cell Lung Cancer: Time for a ReassessmentMartin J Edelman
Clinical Lung Cancer|February 12, 2004
Gemcitabine and carboplatin regimens in advanced non-small-cell lung cancer: focus on randomized phase III trialsMartin J Edelman
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Second-line chemotherapy and beyond for non-small-cell lung cancerMartin J Edelman
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 25, 2010
EML4/ALK and ras inhibitorsMartin J Edelman
Cancer Journal (Sudbury, Mass.)|November 9, 2004
Evidence-based approaches to overcoming barriers to clinical trial accrualMartin J Edelman
Seminars in Oncology|February 7, 2006
An update on the role of epidermal growth factor receptor inhibitors in non-small cell lung cancerMartin J Edelman
Clinical Lung Cancer|October 28, 2005
The potential role of bortezomib in combination with chemotherapy and radiation in non-small-cell lung cancerMartin J Edelman
Lung Cancer (Amsterdam, Netherlands)|November 15, 2002
Past, present, and future of gemcitabine and carboplatin regimens in advanced non-small cell lung cancerMartin J Edelman
Expert Review of Anticancer Therapy|May 2, 2003
Taking stock of targeted therapy in cancer: rational expectations or irrational exuberance?Martin J Edelman
Expert Review of Anticancer Therapy|July 13, 2002
Neoadjuvant chemotherapy in early-stage non-small cell lung cancerM J Edelman
Pageof 35